←Back to structures
BML_coassembly_scaffold_25_prodigal-single.1__X__X__00287
Bact-VirBML_coassembly_scaffold_25_prodigal-single.1__X__X__00287
3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
high
residues 4-117
Domain cluster:
rep: js4906-29-5_S40_scaffold_13_prodigal-single.1__X__X__00046__D3-97
CATH (9)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 1wfxA02 | 3.20.170.30 | Alpha Beta › Alpha-Beta Barrel › ADP-ribosylation fold › | 0.77 | 57.0 | 6.36e-01 | 94.7% | 96.7% |
| 7ri3D01 | 3.90.175.10 | Alpha Beta › Alpha-Beta Complex › Diphtheria Toxin; domain 1 › Diphtheria Toxin, domain 1 | 0.69 | 65.0 | 5.29e-01 | 100.0% | 86.9% |
| 3hkvA00 | 3.90.228.10 | Alpha Beta › Alpha-Beta Complex › Phosphoenolpyruvate Carboxykinase; domain 3 › | 0.68 | 63.0 | 5.23e-01 | 100.0% | 68.2% |
| 1f0lA01 | 3.90.175.10 | Alpha Beta › Alpha-Beta Complex › Diphtheria Toxin; domain 1 › Diphtheria Toxin, domain 1 | 0.67 | 63.0 | 5.25e-01 | 100.0% | 82.4% |
| 6tl1B01 | 3.90.228.10 | Alpha Beta › Alpha-Beta Complex › Phosphoenolpyruvate Carboxykinase; domain 3 › | 0.67 | 62.0 | 5.06e-01 | 100.0% | 67.3% |
| 3b82B00 | 3.90.175.10 | Alpha Beta › Alpha-Beta Complex › Diphtheria Toxin; domain 1 › Diphtheria Toxin, domain 1 | 0.67 | 60.0 | 4.91e-01 | 98.2% | 67.6% |
| 4gv2A02 | 3.90.228.10 | Alpha Beta › Alpha-Beta Complex › Phosphoenolpyruvate Carboxykinase; domain 3 › | 0.66 | 61.0 | 4.92e-01 | 100.0% | 74.3% |
| 1gs0A02 | 3.90.228.10 | Alpha Beta › Alpha-Beta Complex › Phosphoenolpyruvate Carboxykinase; domain 3 › | 0.66 | 60.0 | 4.83e-01 | 100.0% | 72.6% |
| 3q9oA03 | 3.90.175.10 | Alpha Beta › Alpha-Beta Complex › Diphtheria Toxin; domain 1 › Diphtheria Toxin, domain 1 | 0.65 | 59.0 | 4.79e-01 | 98.2% | 70.5% |
ECOD (39)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 4679144 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.79 | 59.0 | 6.46e-01 | 97.4% | 92.6% |
| 4125268 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.79 | 59.0 | 6.57e-01 | 96.5% | 97.8% |
| 4546240 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.78 | 59.0 | 6.57e-01 | 98.2% | 98.9% |
| 5008044 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.77 | 60.0 | 6.57e-01 | 99.1% | 96.8% |
| 4008473 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.77 | 57.0 | 6.12e-01 | 97.4% | 88.9% |
| 4994805 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.77 | 59.0 | 6.26e-01 | 99.1% | 89.3% |
| 4622968 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.77 | 57.0 | 6.36e-01 | 97.4% | 97.8% |
| 4296568 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.76 | 59.0 | 6.39e-01 | 99.1% | 95.8% |
| 4303698 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.76 | 58.0 | 6.33e-01 | 99.1% | 95.7% |
| 3106804 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.76 | 58.0 | 6.08e-01 | 97.4% | 87.4% |
| 5060086 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.74 | 58.0 | 6.32e-01 | 100.0% | 97.9% |
| 5077692 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.73 | 60.0 | 6.22e-01 | 100.0% | 92.4% |
| 3256269 | 237.1.1.0 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation | 0.73 | 62.0 | 6.44e-01 | 97.4% | 96.2% |
| 3258058 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.69 | 65.0 | 5.24e-01 | 100.0% | 57.6% |
| 4822043 | 237.1.1.0 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation | 0.69 | 64.0 | 5.17e-01 | 100.0% | 80.8% |
| 3814112 | 108.1.1.0 ↗ | alpha arrays › EF-hand › EF-hand-related › EF-hand | 0.69 | 64.0 | 5.23e-01 | 100.0% | 63.5% |
| 4880245 | 237.1.1.6 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › Diphtheria_C | 0.68 | 63.0 | 5.29e-01 | 100.0% | 82.8% |
| 3196342 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.68 | 59.0 | 5.03e-01 | 100.0% | 60.3% |
| 3483050 | 237.1.1.18 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › DUF3715 | 0.67 | 61.0 | 4.85e-01 | 100.0% | 67.4% |
| 3908660 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.67 | 62.0 | 5.64e-01 | 100.0% | 82.0% |
| 3262622 | 237.1.1.0 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation | 0.67 | 61.0 | 4.76e-01 | 100.0% | 72.5% |
| 3378730 | 237.1.1.0 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation | 0.67 | 62.0 | 4.96e-01 | 100.0% | 59.3% |
| 3324343 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.67 | 62.0 | 5.13e-01 | 100.0% | 68.4% |
| 3562744 | 237.1.1.18 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › DUF3715 | 0.67 | 62.0 | 4.90e-01 | 100.0% | 68.2% |
| 3724972 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.66 | 59.0 | 4.40e-01 | 100.0% | 40.8% |
| 4876939 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.66 | 61.0 | 5.18e-01 | 100.0% | 65.4% |
| 4865028 | 237.1.1.24 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › Scabin-like | 0.66 | 60.0 | 5.82e-01 | 97.4% | 88.8% |
| 3555152 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.66 | 61.0 | 5.12e-01 | 100.0% | 69.2% |
| 3241341 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.65 | 60.0 | 4.90e-01 | 100.0% | 72.9% |
| 3453008 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.65 | 61.0 | 4.89e-01 | 100.0% | 58.7% |
| 3882775 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.64 | 54.0 | 5.36e-01 | 100.0% | 85.0% |
| 3263315 | 237.1.1.29 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › DUF4291 | 0.64 | 58.0 | 5.00e-01 | 98.2% | 81.1% |
| 3663669 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.64 | 52.0 | 5.30e-01 | 100.0% | 88.5% |
| 3239064 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.64 | 58.0 | 4.64e-01 | 100.0% | 71.6% |
| 4032920 | 237.1.1.11 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › RES | 0.63 | 57.0 | 4.77e-01 | 100.0% | 90.5% |
| 3254451 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.63 | 58.0 | 4.66e-01 | 100.0% | 68.5% |
| 3597511 | 237.1.1.0 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation | 0.61 | 57.0 | 4.72e-01 | 100.0% | 69.7% |
| 3962243 | 4052.1.1.0 ↗ | beta complex topology › Acyl-CoA dehydrogenase middle domain-like › Acyl-CoA dehydrogenase middle domain-like › Acyl-CoA dehydrogenase middle domain-like | 0.60 | 35.0 | 4.18e-01 | 100.0% | 86.7% |
| 3735972 | 237.1.1.36 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › DUF7587 | 0.59 | 53.0 | 4.71e-01 | 96.5% | 87.4% |